期刊文献+

血小板在脓毒症中的研究进展 被引量:2

Research progress of platelets in sepsis
原文传递
导出
摘要 脓毒症为感染致全身免疫失调的炎症反应综合征,血小板在脓毒症发生发展中起着重要作用。血小板可通过黏附、聚集、活化、脱颗粒作用与病原微生物相反应,以达到保护机体的作用。同时,脓毒症时血小板还可与中性粒细胞等免疫细胞相互作用,参与微血栓、炎症的形成。因此,血小板有抗微生物效应及与其他先天免疫细胞协作,形成复杂的血管内免疫防御系统,防止细菌传播的功能。但其介导的免疫功能如果失调,可致宿主细胞和组织受到严重的附带损害,导致脓毒症相关器官功能障碍。本文对血小板在脓毒症及其器官功能障碍中的免疫机制作一综述。 Sepsis is an inflammatory response syndrome caused by systemic immune disorders caused by infection.Platelets play an important role in the development of sepsis.Platelets can react with pathogenic microorganisms through adhesion,aggregation,activation,threshing,and have achieved the role of protecting in the body.At the same time,during sepsis,platelets can also interact with immune cells such as neutrophils and participate in formation of microthrombi and inflammation.Therefore,platelets have an antimicrobial effect and cooperate with other innate immune cells to form a complex intravascular immune defense system to prevent the spread of bacteria.However,if the internal immune function mediated by it is dysregulated,the host cells and tissues may be seriously collaterally damaged,resulting in sepsis-related organ dysfunction.This article reviewed the research progress of platelet immune mechanism and organ dysfunction in sepsis.
作者 陈秋杉 王兴勇 Chen Qiushan;Wang Xingyong(Emergency Department of Children′s Hospital Affiliated to Chongqing Medical University,Chongqing 400014,China)
出处 《中国小儿急救医学》 CAS 2021年第2期145-147,共3页 Chinese Pediatric Emergency Medicine
关键词 脓毒症 血小板 免疫系统 Sepsis Platelet Immune system
  • 相关文献

参考文献10

二级参考文献42

  • 1Margarita Martinez-Medina,Librado Jesus Garcia-Gil.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity[J].World Journal of Gastrointestinal Pathophysiology,2014,5(3):213-227. 被引量:19
  • 2是若春,方雷,刘龙.APACHEⅡ危重病评分系统在ICU的应用[J].中华急诊医学杂志,2005,14(9):783-784. 被引量:42
  • 3王思荣,苏伟,黄昭,陈裕胜,林材元.连续性肾脏替代治疗对重症脓毒症患者凝血系统的影响[J].广东医学,2008,29(2):294-296. 被引量:3
  • 4ODDEN A J, GOVINDAN S, SHETH J, et al. A systematic as- sessment of the surviving sepsis campaign's evidence supporting the care of patients with severe sepsis on the wards[J]. Ann Am Thorac Soc, 2015, 12(6): 956-958.
  • 5BONE R C, BALK R A, CERRA F B, et al. Definitions for sep- sis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference com- mittee, american college of chest physicians/society of critical care medicine[J]. Chest, 1992, 101(6): 1644-1655.
  • 6KNAUS W A, DRAPER E A, WAGNER D P, et al. APACHE II: a severity of disease classification system[J]. Crit Care Med, 1985, 3(10): 818-829.
  • 7MARSHALL J C, COOK D J, CHRISTOU N V, et al. Multiple organ dysfunction score a reliable descriptor of a complex clinical outcome[J} Crit Care Med, 1995, 23(10): 1638-1652.
  • 8DELLINGER R P, LEVY M M, RHODES A, et al. Surviving sepsis campaign: international guidelines for management of se- vere sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2): 580-637.
  • 9RONCO C, TETI'A C, MARIANO F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesi~[J]. Artif Organs, 2003, 270)c 792- 801.
  • 10王小亭,刘大为,隆云,柴文昭,崔娜,石岩,周翔,张青.顽固性感染性休克相关心功能不全患者的血流动力学研究[J].中华内科杂志,2008,47(7):551-555. 被引量:13

共引文献123

同被引文献31

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部